SCHEMBL2227169

SCHEMBL2227169

CS(=O)(=O)c1ccc(S(N)(=O)=O)cc1CNc1cc(Cl)ncn1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CDK1 P06493 1/20 0.40
CCNB1 P14635 1/20 0.40
CCNA2 P20248 1/20 0.40
CCNE1 P24864 1/20 0.40
CDK2 P24941 1/20 0.40
CDK5 Q00535 1/20 0.40
CDK5R1 Q15078 1/20 0.40
SLC6A2 P23975 1/20 0.38
SLC6A4 P31645 1/20 0.38
SLC6A3 Q01959 1/20 0.38
PTGS2 P35354 4/20 0.37
CA1 P00915 5/20 0.37
CA12 O43570 4/20 0.37
CA2 P00918 4/20 0.37
CA9 Q16790 4/20 0.37
BRAF P15056 1/20 0.36
TNNI3K Q59H18 1/20 0.36
ACHE P22303 1/20 0.36
LMNA P02545 1/20 0.36
ALDH1A1 P00352 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2227374 0.85 CDK1 (0.51) CDK1CCNB1CCNA2CCNE1CDK2
SCHEMBL2226261 0.83 TNNI3K (0.58) CDK1CCNB1CCNA2CCNE1CDK2
SCHEMBL2227255 0.83 SLC6A4 (0.40) CDK1CCNB1CCNA2CCNE1CDK2
SCHEMBL2225414 0.79 CDK1 (0.46) CDK1CCNB1CCNA2CCNE1CDK2
SCHEMBL2226542 0.78 CCNA2 (0.48) CDK1CCNB1CCNA2CCNE1CDK2
Trifluoroacetic Acid SCHEMBL2225019 0.78 TNNI3K (0.44) CDK1CCNB1CCNA2CCNE1CDK2
SCHEMBL2226017 0.78 BRAF (0.43) CDK1CCNB1CCNA2CCNE1CDK2
SCHEMBL2225921 0.78 CDK1 (0.42) CDK1CCNB1CCNA2CCNE1CDK2
SCHEMBL2226380 0.77 CCNA2 (0.47) CDK1CCNB1CCNA2CCNE1CDK2
SCHEMBL2225764 0.76 CDK1 (0.38) CDK1CCNB1CCNA2CCNE1CDK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2523559-A1 COMPOUNDS AND METHODS GlaxoSmithKline LLC (US) 2012-11-21 EP disclosed
WO-2011088027-A1 COMPOUNDS AND METHODS GLAXOSMITHKLINE LLC (US) 2011-07-21 WO disclosed